An2 Therapeutics, Inc. · NASDAQ:ANTX

Martin Patricia A. received 766 An2 Therapeutics, Inc. shares as an award (Form 4)

Traded Jul 10, 2026 · Filed Jul 10, 2026

On Jul 10, 2026, Martin Patricia A. (Director) received 766 An2 Therapeutics, Inc. shares as an award, leaving 18,863 shares. Filed Jul 10, 2026 (Form 4).

Awarded
766 shares
Holding after
18,863 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 10, 2026Common StockAward76618,863Direct

Source

View original at SEC

Related